Filter
5402
Filtered Results: 5402
Text search:
drug
access
Featured
Recommendations
469
New Publications
1439
Language
Document type
No document type
3364
Studies & Reports
824
Guidelines
635
Manuals
220
Strategic & Response Plan
157
Fact sheets
78
Training Material
60
Situation Updates
27
Infographics
17
Resource Platforms
9
Brochures
5
Online Courses
4
App
2
Countries / Regions
India
301
Global
170
Kenya
166
South Africa
140
Uganda
126
Ethiopia
122
Western and Central Europe
121
Nigeria
113
Nepal
93
Tanzania
90
Liberia
88
Sierra Leone
87
Malawi
86
Africa
81
Zambia
80
Myanmar / Burma
77
Latin America and the Carribbean
69
Bangladesh
69
Ghana
66
Rwanda
66
Eastern Europe
65
Ukraine
59
Philippines
47
Namibia
46
Zimbabwe
45
Asia
43
Cambodia
37
Lesotho
36
South–East Asia Region
35
Russia
33
Syria
29
Congo, Democratic Republic of
27
Senegal
26
Botswana
26
Indonesia
26
Mozambique
24
Burkina Faso
21
Colombia
19
Middle East and North Africa
19
East and Southern Africa
19
Brazil
19
South Sudan
19
Eswatini/ Swaziland
19
West and Central Africa
17
Cameroon
16
Tajikistan
14
Haiti
14
Albania
13
USA
13
Venezuela
13
Eastern Europe and Central Asia
13
Germany
12
Thailand
11
Guinea
11
Argentina
11
Vietnam
10
Georgia
10
Pakistan
10
Benin
9
Afghanistan
9
Moldova
9
China
8
Peru
8
Sudan
8
Yemen
8
Laos
7
Armenia
7
Paraguay
7
North Macedonia
6
Mexico
6
El Salvador
6
Western Pacific Region
6
Chile
5
Jordan
5
Lebanon
5
Sri Lanka
5
Central African Republic
5
Iraq
5
Turkey
4
Jamaica
4
United Kingdom
4
Southern Africa
4
Bolivia
4
Mali
4
Libya
4
Somalia
4
Timor Leste/ East Timor
3
Iran
3
Kyrgyzstan
3
North America
3
Spain
3
Côte d’Ivoire / Ivory Coast
3
Papua New Guinea
3
Palestine
3
Angola
3
Bhutan
3
Madagascar
3
Serbia
2
Kazakhstan
2
Canada
2
Fiji
2
Estonia
2
Uzbekistan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Saudi Arabia
2
Gabon
2
Uruguay
2
France
2
Portugal
2
Belarus
2
Romania
2
Poland
2
Honduras
2
North Korea
1
Switzerland
1
Australia
1
Gambia
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Malaysia
1
Mongolia
1
Qatar
1
Bulgaria
1
Italy
1
Lithuania
1
Ireland
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Norway
1
Nicaragua
1
Egypt
1
Greece
1
Chad
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2063
Clinical Guidelines
461
Public Health
260
Women & Child Health
212
Key Resources
108
Capacity Building
81
Pharmacy & Technologies
57
Annual Report MEDBOX
1
Toolboxes
HIV
707
TB
539
Mental Health
530
AMR
268
COVID-19
234
Pharmacy
161
NTDs
161
NCDs
106
Caregiver
104
Rapid Response
84
Ebola
81
Planetary Health
73
Refugee
71
Conflict
65
Disability
62
Global Health Education
57
Health Financing Toolbox
37
Natural Hazards
19
Polio
19
Cholera
18
Social Ethics
16
Zika
16
Specific Hazards
14
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable ...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for...
Research Article
Hindawi
BioMed Research International
Volume 2018, Article ID 9619684, 10 pages https://doi.org/10.1155/2018/9619684
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report...
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens.
Results are used to inform A...
High prices, hard-to-access human insulin, few insulin producers, and weak health systems are just some of the barriers that people with diabetes face a century after insulin was discovered, WHO notes in a new report
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Medicines and Health Products Price and Availability Monitoring Mobile Application. This tool fac...
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o...
Front. Public Health, 30 April 2021 | https://doi.org/10.3389/fpubh.2021.628744
Preventing tuberculosis infection from progressing to tuberculosis disease is a crucial component of the goal to eliminate tuberculosis. When deciding on the use of tuberculosis preventive therapy among household contacts, policy makers regularly ask questions, such as whether tuberculosis preventiv...
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
People with disabilities experience significant health inequalities. In Malawi, where most individuals live in low-income rural settings, many of these inequalities are exacerbated by restricted access to health care services. This qualitative study explores the barriers to health care access experi...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
